Assobiotec - English version

16 November 2023

Momentum Biotechnologies and Axxam S.p.A. Announce Collaboration to Provide Unique Drug Discovery Solutions

Through the partnership Axxam’s highly curated chemical diversity library, comprised of 325,000 compounds, will be available for high-throughput screening using Momentum’s mass spectrometry-based func􀀛onal and binding assay platforms.

09 November 2023

Assobiotec signs an agreement with the European Biosolutions Coalition

Assobiotec has signed, in the framework of the Ecomondo Fair, an agreement with the European Biosolutions Coalition: an international reality born last 26 October in Brussels, with the aim of identifying and overcoming the European regulatory obstacles that slow down the spread of biotechnological solutions in the agricultural and industrial fields

02 November 2023

Highlights of the 5th edition of HTID®, organized by HealthTech For Care

Assobiotec was a partner of the HealthTech Innovation Days (HTID®) that brought together 750 participants on October 24 and 25, and remotely on October 27, including researchers, public players, industry leaders, patients’ associations, patients, investors and entrepreneurs in Paris.

13 September 2023

HealthTech Innovation Days 2023 Program announced

Flagship event in the European health innovation ecosystem, organized in Paris with the support of Life Sciences Leaders

19 July 2023

HealthTech For Care, its sponsors, and supporters adapt the 5th edition of HealthTech Innovation Days to the uncertain economic and financial context in Europe

The development of medical innovation for the benefit of European patients is going through uncertain financial times. The economic impact on the development of European HealthTech companies is a real challenge. In order to support medical innovation for the benefit of patients, HealthTech For Care, its sponsors and supporters are providing a concrete solution for these companies through HealthTech Innovation Days (HTID), by modifying the participation criteria for companies, in order to welcome early-stage companies.

18 July 2023

Biotechnology: a strategic and growing sector with over 13 billion in turnover

More than 800 companies, 13,700 employees, over 13 billion in turnover estimated in 2022 and a market that is recording growth on various variables testifying to a resilient, dynamic and strategic sector for the development of the country. This is what emerges from the economic update of the ENEA-Assobiotec report "Biotechnology companies in Italy", now in its 8th edition, presented today in an online event.

Go to the

Events

News

Momentum Biotechnologies and Axxam S.p.A. Announce Collaboration to Provide Unique Drug Discovery Solutions

Assobiotec signs an agreement with the European Biosolutions Coalition

Highlights of the 5th edition of HTID®, organized by HealthTech For Care

HealthTech Innovation Days 2023 Program announced

HealthTech For Care, its sponsors, and supporters adapt the 5th edition of HealthTech Innovation Days to the uncertain economic and financial context in Europe

Biotechnology: a strategic and growing sector with over 13 billion in turnover

Partner

Where to find us